Literature DB >> 30151710

Regulation of geminin by neuropeptide Y in vascular smooth muscle cell proliferation : A current review.

S-Y Liang1, Y-L Zhou1, M-Q Shu2, S Lin3,4.   

Abstract

Geminin, a key regulator of DNA replication licensing in the cell cycle, plays an essential role in determining the fate of cells via suppression of cell proliferation and cellular differentiation. Neuropeptide Y (NPY) intensifies the proliferation of vascular smooth muscle cells (VSMCs) directly by binding with Y1 receptors. In vitro experiments have shown that stimulation of NPY on VSMCs via regulation of geminin is a double-edged sword. Given that the proliferation and the phenotypic transformation of VSMCs increase the risk for progression of atherosclerosis, we focus on the role of geminin interference in determining the fate of VSMCs. Furthermore, we discuss the therapeutic potential of peripheral neurotransmitter interference, thus pointing toward future research directions in the treatment of atherosclerosis.

Entities:  

Keywords:  Atherosclerosis; Cell cycle; DNA replication; Neuropeptide Y; Neurotransmitter

Year:  2018        PMID: 30151710     DOI: 10.1007/s00059-018-4721-3

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  37 in total

1.  Structural basis for homeodomain recognition by the cell-cycle regulator Geminin.

Authors:  Bo Zhou; Changdong Liu; Zhiwen Xu; Guang Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

Review 2.  Geminin-Cdt1 balance is critical for genetic stability.

Authors:  Sandeep Saxena; Anindya Dutta
Journal:  Mutat Res       Date:  2005-01-06       Impact factor: 2.433

3.  Different effects of neuropeptide Y on proliferation of vascular smooth muscle cells via regulation of Geminin.

Authors:  Zhou-Qin Jiang; You-Li Zhou; Xia Chen; Lin-Yu Li; Shi-Yu Liang; Shu Lin; Mao-Qin Shu
Journal:  Mol Cell Biochem       Date:  2017-04-06       Impact factor: 3.396

4.  NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.

Authors:  S Crnkovic; B Egemnazarov; P Jain; U Seay; N Gattinger; L M Marsh; Z Bálint; G Kovacs; B Ghanim; W Klepetko; R T Schermuly; N Weissmann; A Olschewski; G Kwapiszewska
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 5.  Benzylpiperazine: "A messy drug".

Authors:  D P Katz; J Deruiter; D Bhattacharya; M Ahuja; S Bhattacharya; C R Clark; V Suppiramaniam; M Dhanasekaran
Journal:  Drug Alcohol Depend       Date:  2016-05-06       Impact factor: 4.492

Review 6.  Anti-atherosclerotic plants which modulate the phenotype of vascular smooth muscle cells.

Authors:  Tuqa Saleh Al-Shehabi; Rabah Iratni; Ali H Eid
Journal:  Phytomedicine       Date:  2015-11-21       Impact factor: 5.340

Review 7.  Role of Geminin in cell fate determination of hematopoietic stem cells (HSCs).

Authors:  Shin'ichiro Yasunaga; Yoshinori Ohno; Naoto Shirasu; Bo Zhang; Kyoko Suzuki-Takedachi; Motoaki Ohtsubo; Yoshihiro Takihara
Journal:  Int J Hematol       Date:  2016-07-15       Impact factor: 2.490

8.  Polycomb-group complex 1 acts as an E3 ubiquitin ligase for Geminin to sustain hematopoietic stem cell activity.

Authors:  Motoaki Ohtsubo; Shin'ichiro Yasunaga; Yoshinori Ohno; Miyuki Tsumura; Satoshi Okada; Nobutsune Ishikawa; Kenichiro Shirao; Akira Kikuchi; Hideo Nishitani; Masao Kobayashi; Yoshihiro Takihara
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

9.  An inactive geminin mutant that binds cdt1.

Authors:  Marissa Suchyta; Benoit Miotto; Thomas J McGarry
Journal:  Genes (Basel)       Date:  2015-05-15       Impact factor: 4.096

10.  Cell cycle-dependent subcellular translocation of the human DNA licensing inhibitor geminin.

Authors:  Maria Dimaki; Georgia Xouri; Ioanna-Eleni Symeonidou; Chaido Sirinian; Hideo Nishitani; Stavros Taraviras; Zoi Lygerou
Journal:  J Biol Chem       Date:  2013-06-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.